Transdermal application form of calcium antagonists

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Web – sheet or filament bases; compositions of bandages; or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424445, 424448, A61K 1300

Patent

active

047770473

ABSTRACT:
The use of permeation enhancers permits the formulation of transdermal dosage forms for calcium antagonists. These dosage forms are administrable to humans and other mammals, e.g., bovines.

REFERENCES:
patent: 4637930 (1987-01-01), Konno et al.
patent: 4685911 (1987-08-01), Konno et al.
Journal of Pharmaceutical Sciences, 8/84, E. R. Cooper; "Increased Skin Permeability for Lipophilic Molecules".
Chemical Abstracts, vol. 96, 2/82; Seite 378, Ref. No. 40902j, Taisho Pharm. Co. Ltd., JPA 81110614.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Transdermal application form of calcium antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal application form of calcium antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal application form of calcium antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1957541

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.